Pulmonary function tests (PFTs) are invaluable tools in the diagnosis, monitoring, and management of respiratory diseases. The interpretation of these tests, however, can be complex and challenging, necessitating a comprehensive understanding for accurate clinical application.
PFTs primarily assess three parameters: lung volumes, airflow, and gas exchange. Forced Vital Capacity (FVC), Forced Expiratory Volume in 1 second (FEV1), and their ratio (FEV1/FVC) are the key indicators of airflow. Total Lung Capacity (TLC), Residual Volume (RV), and Functional Residual Capacity (FRC) depict lung volumes. Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) measures gas exchange.
Spirometry is the cornerstone of PFTs. Normal FEV1/FVC ratio is above 0.7. A decreased ratio suggests obstructive disease, while normal or increased ratio with decreased volumes indicates restrictive pattern. The severity of obstruction or restriction is classified based on FEV1 or FVC percentages of predicted values.
Increased RV and FRC suggest air trapping, common in obstructive diseases. Decreased TLC indicates restrictive disease. A reduced DLCO points towards impaired gas exchange, seen in interstitial lung disease and pulmonary vascular disorders. However, it might be normal in pure airway diseases like asthma.
Interpretation of PFTs should always be integrated with clinical context and other investigations. For instance, a normal DLCO in a patient with reduced volumes and FEV1/FVC ratio may favor a diagnosis of asthma over COPD. Conversely, a reduced DLCO in a patient with normal spirometry could suggest early interstitial lung disease.
Interpreting PFTs is a vital skill for healthcare professionals involved in respiratory care. A thorough understanding of the basic parameters, coupled with an ability to integrate these results with clinical context, can greatly enhance diagnostic accuracy and patient management.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation